The US Food and Drug Administration has already authorized the emergency use of two COVID-19 vaccines developed by Moderna and Pfizer. Both vaccines use mRNA technology, a relatively new type of treatment that works by providing instructions to healthy cells to generate antibodies for a certain virus or bacterium.